Amphastar Pharmaceuticals Inc (AMPH)-Financial and Strategic SWOT Analysis Review

Amphastar Pharmaceuticals Inc (AMPH)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH94919FSA
  • |
  • Pages: 41
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Amphastar Pharmaceuticals Inc (AMPH)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient (insulin API) products. Amphastar's products includes enoxaparin sodium injection; cosyntropin for injection; naloxone HCl injection and phytonadione injection; ketorolac tromethamine injection, USP; emergency syringes in Luer-Jet; lidocaine HCl Jelly, USP, 2%; amphadase hyaluronidase injection, USP; and lidocaine HCl, 4% topical solution. The company offers its products to alternate care sites, hospitals, clinics and doctors' offices, and long-term care facilities. The company operates manufacturing facilities in Eragnysur-Epte, France; Rancho Cucamonga and South El Monte, California; Canton, Massachusetts; and Nanjing, China. It market products through specialty distributors, wholesalers, retailers and subsidiaries in the US, the UK, France and China. Amphastar is headquartered in Rancho Cucamonga, California, the US.

Amphastar Pharmaceuticals Inc Key Recent Developments

Mar 13,2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2016

Nov 08,2016: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2016

Aug 08,2016: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2016

May 09,2016: Amphastar Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Amphastar Pharmaceuticals Inc-Key Facts 5

Amphastar Pharmaceuticals Inc-Key Employees 6

Amphastar Pharmaceuticals Inc-Key Employee Biographies 7

Amphastar Pharmaceuticals Inc-Major Products and Services 8

Amphastar Pharmaceuticals Inc-History 9

Amphastar Pharmaceuticals Inc-Company Statement 10

Amphastar Pharmaceuticals Inc-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2-Company Analysis 13

Amphastar Pharmaceuticals Inc-Business Description 13

Amphastar Pharmaceuticals Inc-Corporate Strategy 14

Amphastar Pharmaceuticals Inc-SWOT Analysis 15

SWOT Analysis-Overview 15

Amphastar Pharmaceuticals Inc-Strengths 15

Amphastar Pharmaceuticals Inc-Weaknesses 16

Amphastar Pharmaceuticals Inc-Opportunities 17

Amphastar Pharmaceuticals Inc-Threats 18

Amphastar Pharmaceuticals Inc-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 24

Financial Performance 24

Financial Ratios-Interim Ratios 25

Financial Ratios-Ratio Charts 26

Section 4-Company's Lifesciences Financial Deals and Alliances 27

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Amphastar Pharmaceuticals Inc, Recent Deals Summary 29

Section 5-Company's Recent Developments 30

Mar 13, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2016 30

Nov 08, 2016: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2016 32

Aug 08, 2016: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2016 33

May 09, 2016: Amphastar Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2016 35

Section 6-Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41

List of Figures

Amphastar Pharmaceuticals Inc, Performance Chart (2012-2016) 24

Amphastar Pharmaceuticals Inc, Ratio Charts 26

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 28

List of Tables

Amphastar Pharmaceuticals Inc, Key Facts 5

Amphastar Pharmaceuticals Inc, Key Employees 6

Amphastar Pharmaceuticals Inc, Key Employee Biographies 7

Amphastar Pharmaceuticals Inc, Major Products and Services 8

Amphastar Pharmaceuticals Inc, History 9

Amphastar Pharmaceuticals Inc, Other Locations 11

Amphastar Pharmaceuticals Inc, Subsidiaries 11

Amphastar Pharmaceuticals Inc, Key Competitors 19

Amphastar Pharmaceuticals Inc, Ratios based on current share price 20

Amphastar Pharmaceuticals Inc, Annual Ratios 21

Amphastar Pharmaceuticals Inc, Annual Ratios (Cont...1) 22

Amphastar Pharmaceuticals Inc, Annual Ratios (Cont...2) 23

Amphastar Pharmaceuticals Inc, Interim Ratios 25

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Amphastar Pharmaceuticals Inc, Recent Deals Summary 29

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Teva Pharmaceutical Industries Ltd Sandoz Inc Sagent Pharmaceuticals Inc Mylan Inc Fresenius Kabi USA LLC Akorn Inc

select a license

Single User License
USD 125 INR 8070
Site License
USD 250 INR 16140
Corporate User License
USD 375 INR 24210

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com